BREAKING
Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 5 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 5 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 5 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 5 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 5 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 5 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 5 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 5 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 5 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 5 hours ago Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 5 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 5 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 5 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 5 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 5 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 5 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 5 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 5 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 5 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 5 hours ago
LLY

Eli Lilly and Company

$LLY NYSE Aug 3, 2021 BMO Q2 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

LLY Coverage

Event Eli Lilly and Company (LLY) Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Feb 18, 2026 Event Eli Lilly and Company (LLY) TD Cowen’s 46th Annual Health Care Conference Feb 16, 2026 Event Eli Lilly and Company (LLY) Lilly’s Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer Feb 16, 2026 News Eli Lilly and Company (LLY) to acquire Orna Therapeutics Feb 9, 2026 News Key highlights from Eli Lilly’s (LLY) Q4 2025 earnings results Feb 4, 2026 Transcript Eli Lilly and Company (LLY) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Eli Lilly and Company (LLY) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Eli Lilly (LLY) Earnings: 3Q25 Key Numbers Oct 30, 2025